PRAECIS PHARMACEUTICALS INCORPORATED to Announce Second Quarter Financial Results on Friday, August 4, 2006
02 August 2006 - 6:30AM
Business Wire
PRAECIS PHARMACEUTICALS INCORPORATED (NASDAQ: PRCS), today
announced that it will report Second Quarter 2006 financial results
on Friday, August 4, 2006, before the financial markets open.
Company management will host a conference call beginning at 9:00
a.m., EDT, with members of the investment community. The Company's
conference call may be accessed live by visiting PRAECIS' website
at http://www.praecis.com under "Investors" and "Webcast Live."
Interested parties also may listen to a replay of the call
beginning Friday, August 4, at 12:00 Noon, EDT, until midnight
Friday, August 11, by calling 888-203-1112 or 719-457-0820, and
entering the passcode 4327855. PRAECIS PHARMACEUTICALS INCORPORATED
is a biopharmaceutical company focused on the discovery and
development of novel compounds that have the potential to address
unmet medical needs or improve existing therapies. PRAECIS has a
novel MetAP-2 inhibitor, PPI-2458, in clinical development for
cancer indications, including non-Hodgkin's lymphoma and solid
tumors, as well as an innovative drug discovery technology,
DirectSelect(TM), which enables the generation and practical use of
ultra-large libraries for the discovery of orally active compounds
for drug development.
Praecis (NASDAQ:PRCS)
Historical Stock Chart
From Oct 2024 to Nov 2024
Praecis (NASDAQ:PRCS)
Historical Stock Chart
From Nov 2023 to Nov 2024
Real-Time news about Praecis Pharmaceuticals (MM) (NASDAQ): 0 recent articles
More PRAECIS PHARMACEUTICALS INCORPORATED News Articles